Orthofix Medical Inc. (NASDAQ:OFIX) Shares Acquired by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. boosted its holdings in shares of Orthofix Medical Inc. (NASDAQ:OFIX - Free Report) by 14.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 324,807 shares of the medical device company's stock after buying an additional 39,901 shares during the period. Charles Schwab Investment Management Inc. owned approximately 0.85% of Orthofix Medical worth $5,073,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently bought and sold shares of the company. Price T Rowe Associates Inc. MD lifted its stake in Orthofix Medical by 3.9% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 32,957 shares of the medical device company's stock valued at $479,000 after acquiring an additional 1,236 shares during the period. Bank of New York Mellon Corp increased its holdings in Orthofix Medical by 6.8% in the second quarter. Bank of New York Mellon Corp now owns 143,772 shares of the medical device company's stock valued at $1,906,000 after buying an additional 9,118 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in Orthofix Medical by 25.5% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,435 shares of the medical device company's stock valued at $125,000 after purchasing an additional 1,919 shares during the period. nVerses Capital LLC acquired a new stake in shares of Orthofix Medical in the second quarter valued at about $27,000. Finally, Victory Capital Management Inc. acquired a new stake in shares of Orthofix Medical in the second quarter worth approximately $832,000. 89.76% of the stock is currently owned by institutional investors and hedge funds.

Orthofix Medical Stock Down 0.2 %

OFIX traded down $0.03 during midday trading on Friday, reaching $18.06. 38,337 shares of the company's stock were exchanged, compared to its average volume of 322,076. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.11 and a current ratio of 2.39. Orthofix Medical Inc. has a 1-year low of $11.86 and a 1-year high of $20.73. The business's 50-day moving average price is $17.50 and its 200 day moving average price is $16.04.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on OFIX shares. Stifel Nicolaus upgraded shares of Orthofix Medical from a "hold" rating to a "buy" rating and boosted their price target for the stock from $18.00 to $24.00 in a research report on Friday, November 8th. Roth Mkm reaffirmed a "buy" rating and issued a $22.00 target price (up from $20.00) on shares of Orthofix Medical in a research report on Friday, November 8th. Two equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat, Orthofix Medical has a consensus rating of "Moderate Buy" and an average target price of $23.00.

Orthofix Medical Company Profile

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.